Showing posts with label pilot. Show all posts
Showing posts with label pilot. Show all posts

Thursday, March 14, 2019

TraceLink proposes blockchain system for DSCSA pilot - SecuringIndustry.com

Read the full article:  TraceLink proposes blockchain system for DSCSA pilot - SecuringIndustry.com

"TraceLink says that its offering – called Trace Histories – is built on its digital supply network which is already widely used in the pharma supply chain. Adding blockchain means that it can now offer a system that is “designed specifically to help pharmaceutical manufacturers, wholesale distributors, pharmacies, and hospitals securely exchange information and satisfy the 2023 DSCSA requirement.”"

Return Home:  The Designated Representative and Exemptee Blog

-----------------

California Designated Representative Training Courses (approved by the California State Board of Pharmacy) - for wholesalers, third-party logistics providers (3PL), or reverse distributors
California Designated Representative Training Courses (approved by the California State Board of Pharmacy) - for wholesalers, third-party logistics providers (3PL), or reverse distributors


For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Friday, February 8, 2019

Pilot Project Program Under the DSCSA - FDA Notice

Updated June 13, 2026

You might also like:

Drug Supply Chain Security Act (DSCSA) - FDA.gov:
https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa

---  the original post follows below  ---

"The DSCSA outlines critical steps to build an electronic, interoperable system by November 27, 2023, that will identify and trace certain prescription drugs as they are distributed within the United States."  
The "FDA is seeking pilot project participants from the pharmaceutical distribution supply chain (e.g., authorized manufacturers, repackagers, wholesale distributors, and dispensers) and other stakeholders. FDA expects potential participants to propose the design and execution of their pilot project in their submission to FDA; however, FDA intends to meet with selected pilot project participants to ensure that the learnings from the pilot project(s) will be complementary in informing all stakeholders in the development of the electronic, interoperable system that will go into effect in 2023."


For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Custom Search

From SkillsPlus International Inc.